Missed NVDA?
Don’t Miss the Next One.
Join 5,000+ investors using Ticker Nerd’s Market Radar to stay ahead of major market moves, analyst upgrades, and trending opportunities — for free.
NGVT Stock Forecast 2025-2026
$48.40
Current Price
$1.76B
Market Cap
Buy 3
Hold 1
Sell 0
Wall St Analyst Ratings
Distance to NGVT Price Targets
+59.1%
To High Target of $77.00
+44.6%
To Median Target of $70.00
+7.4%
To Low Target of $52.00
NGVT Price Momentum
-9.9%
1 Week Change
-10.4%
1 Month Change
+7.0%
1 Year Change
+18.8%
Year-to-Date Change
-20.4%
From 52W High of $60.77
+69.9%
From 52W Low of $28.49
📊 TOP ANALYST CALLS
Did NGVT Make This Month's Elite Buy List?
We don't follow just any analyst — only the top 3% with a proven track record make our cut. See if Ingevity is one of their latest high-conviction picks.
Latest NGVT Stock Price Targets & Analyst Predictions
Based on our analysis of 10 Wall Street analysts, NGVT has a bullish consensus with a median price target of $70.00 (ranging from $52.00 to $77.00). The overall analyst rating is Strong Buy (8.5/10). Currently trading at $48.40, the median forecast implies a 44.6% upside. This outlook is supported by 3 Buy, 1 Hold, and 0 Sell ratings.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
NGVT Analyst Ratings
3
Buy
1
Hold
0
Sell
NGVT Price Target Range
Low
$52.00
Average
$70.00
High
$77.00
Current: $48.40
Latest NGVT Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for NGVT.
| Date | Firm | Analyst | Rating | Change | Price Target |
|---|---|---|---|---|---|
| Sep 5, 2025 | BMO Capital | John McNulty | Outperform | Maintains | $68.00 |
| Aug 7, 2025 | BMO Capital | John McNulty | Outperform | Maintains | $62.00 |
| Jul 14, 2025 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $48.00 |
| May 7, 2025 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $38.00 |
| Apr 9, 2025 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $32.00 |
| Feb 26, 2025 | BMO Capital | John McNulty | Outperform | Upgrade | $65.00 |
| Feb 20, 2025 | BMO Capital | John McNulty | Market Perform | Maintains | $62.00 |
| Oct 31, 2024 | BMO Capital | John McNulty | Market Perform | Maintains | $47.00 |
| Sep 30, 2024 | BMO Capital | John McNulty | Market Perform | Maintains | $40.00 |
| Aug 5, 2024 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $40.00 |
| Aug 5, 2024 | BMO Capital | John McNulty | Market Perform | Maintains | $42.00 |
| Aug 1, 2024 | Oppenheimer | Ian Zaffino | Outperform | Maintains | $50.00 |
| Jul 11, 2024 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $45.00 |
| May 8, 2024 | BMO Capital | John McNulty | Market Perform | Maintains | $55.00 |
| May 7, 2024 | Loop Capital | Christopher Kapsch | Hold | Maintains | $56.00 |
| May 2, 2024 | Oppenheimer | Ian Zaffino | Outperform | Maintains | $58.00 |
| Apr 22, 2024 | Jefferies | Daniel Rizzo | Buy | Upgrade | $62.00 |
| Feb 23, 2024 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $50.00 |
| Nov 9, 2023 | BMO Capital | John McNulty | Market Perform | Maintains | $43.00 |
| Oct 3, 2023 | Loop Capital | Christopher Kapsch | Hold | Downgrade | $53.00 |
Ingevity Corporation (NGVT) Competitors
The following stocks are similar to Ingevity based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Ingevity Corporation (NGVT) Financial Data
Ingevity Corporation has a market capitalization of $1.76B with a P/E ratio of 13.0x. The company generates $1.38B in trailing twelve-month revenue with a -4.8% profit margin.
Revenue growth is -11.6% quarter-over-quarter, while maintaining an operating margin of +24.9% and return on equity of -204.7%.
Valuation Metrics
Market Cap
$1.76B
Enterprise Value
$2.93B
P/E Ratio
13.0x
PEG Ratio
-0.3x
Price/Sales
1.3x
Growth & Margins
Revenue Growth (YoY)
-11.6%
Gross Margin
+37.8%
Operating Margin
+24.9%
Net Margin
-4.8%
EPS Growth
-6.5%
Financial Health
Cash/Price Ratio
+4.7%
Current Ratio
1.3x
Debt/Equity
912.7x
ROE
-204.7%
ROA
+8.1%
💡 SKIP THE NOISE
97% of Analyst Ratings Go Nowhere
We filter thousands of calls to find the few that actually matter. Get the top analyst buy ratings — tracked and updated every Monday and Thursday.
Ingevity Corporation (NGVT) Business Model
About Ingevity Corporation
What They Do
Manufacturer of specialty chemicals and carbon materials.
Business Model
Ingevity Corporation generates revenue by producing specialty chemicals and high-performance carbon materials, particularly for the automotive industry. Its activated carbon products help reduce vehicle emissions, while its chemical solutions support various applications, including adhesives and lubricants, catering to a diverse range of sectors such as transportation and construction.
Additional Information
With decades of experience, Ingevity emphasizes sustainability and responsible manufacturing processes. The company's innovative solutions are essential for enhancing product performance and promoting environmental compliance, making it a key player in the specialty chemicals market.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
1,600
CEO
Mr. David H. Li
Country
United States
IPO Year
2016
Website
www.ingevity.comIngevity Corporation (NGVT) Latest News & Analysis
Latest News
Quick Summary
Ingevity Corporation (NGVT) will hold its Q3 2025 earnings call on November 6, 2025, at 10:00 AM EST, featuring key company executives and analysts from various firms.
Why It Matters
The earnings call provides key insights into Ingevity's financial performance and future outlook, influencing stock valuation and investor confidence.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Ingevity Corporation (NYSE: NGVT) has released its financial results for Q3 2025. Further details on performance metrics were not included in the excerpt.
Why It Matters
Ingevity's Q3 2025 financial results can impact stock performance, indicating growth potential or challenges that may affect investor sentiment and portfolio decisions.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
Ingevity will hold a virtual Strategic Portfolio Update for investors on December 8, 2025, at 9:00 a.m. Eastern.
Why It Matters
Ingevity's upcoming strategic update may reveal future growth plans or changes in strategy, impacting investor sentiment and stock performance.
Source: Business Wire
Market Sentiment:
Neutral
Quick Summary
The London Company Small Cap portfolio rose 1.9% gross this quarter, underperforming the Russell 2000's 12.4%. Armstrong World Industries excelled, while Interparfums struggled due to cautious retailer inventory management.
Why It Matters
The London Company Small Cap portfolio's underperformance versus the Russell 2000 highlights potential risks in small-cap investments. Armstrong's strong results may indicate growth opportunities, while Interparfums signals caution in retail and fragrance sectors.
Source: Seeking Alpha
Market Sentiment:
Neutral
Quick Summary
Ingevity Corporation will release its Q3 2025 earnings on November 5, 2025, after the market closes.
Why It Matters
Ingevity's upcoming earnings release could impact stock prices, provide insights into financial health, and influence investor sentiment and market trends.
Source: Business Wire
Market Sentiment:
Neutral
Ingevity names Ruth Castillo as senior vice president and president of Performance Materials
16 days ago
Quick Summary
Ingevity Corporation has appointed Ruth Castillo as president of its activated carbon segment, Performance Materials.
Why It Matters
Leadership changes can impact company strategy and performance, potentially affecting stock prices and investor confidence in Ingevity Corporation's future growth.
Source: Business Wire
Market Sentiment:
Neutral
Frequently Asked Questions About NGVT Stock
What is Ingevity Corporation's (NGVT) stock forecast for 2026?
Based on our analysis of 10 Wall Street analysts, Ingevity Corporation (NGVT) has a median price target of $70.00. The highest price target is $77.00 and the lowest is $52.00.
Is NGVT stock a good investment in 2026?
According to current analyst ratings, NGVT has 3 Buy ratings, 1 Hold ratings, and 0 Sell ratings. The stock is currently trading at $48.40. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for NGVT stock?
Wall Street analysts predict NGVT stock could reach $70.00 in the next 12 months. This represents a 44.6% increase from the current price of $48.40. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Ingevity Corporation's business model?
Ingevity Corporation generates revenue by producing specialty chemicals and high-performance carbon materials, particularly for the automotive industry. Its activated carbon products help reduce vehicle emissions, while its chemical solutions support various applications, including adhesives and lubricants, catering to a diverse range of sectors such as transportation and construction.
What is the highest forecasted price for NGVT Ingevity Corporation?
The highest price target for NGVT is $77.00 from at , which represents a 59.1% increase from the current price of $48.40.
What is the lowest forecasted price for NGVT Ingevity Corporation?
The lowest price target for NGVT is $52.00 from at , which represents a 7.4% increase from the current price of $48.40.
What is the overall NGVT consensus from analysts for Ingevity Corporation?
The overall analyst consensus for NGVT is bullish. Out of 10 Wall Street analysts, 3 rate it as Buy, 1 as Hold, and 0 as Sell, with a median price target of $70.00.
How accurate are NGVT stock price projections?
Stock price projections, including those for Ingevity Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.
Last updated: November 8, 2025 2:43 PM UTC